Zur Kurzanzeige

dc.contributor.authorSánchez Montejo, Javier 
dc.contributor.authorTeodosio, Cristina 
dc.contributor.authorStrilets, Tania
dc.contributor.authorLópez Abán, Julio 
dc.contributor.authorManzano Román, Raúl 
dc.contributor.authorMartín, Silvia
dc.contributor.authorSilos, Lidia
dc.contributor.authorTrujillo, Ignacio
dc.contributor.authorGarcia Blanco, Mariano A.
dc.contributor.authorVicente, Belén
dc.contributor.authorMuro, Antonio
dc.coverage.spatialSalamanca (España), lat=40.96882; long= -5.66388es_ES
dc.coverage.temporal2024es_ES
dc.date.accessioned2025-10-17T12:04:23Z
dc.date.available2025-10-17T12:04:23Z
dc.date.issued2025
dc.identifier.citationSánchez Montejo, J. , Teodosio, C., Strilets, T., López Albán, J., Manzano Román, R., Martín, S., Silos, L., Trujillo, I., Garcia Blanco, M., Vicente, V. y Muro, A. (2025). Raw data of Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a Fatty Acid Binding Protein vaccine [Dataset]. Octubre 2025. GREDOS. http://hdl.handle.net/10366/167455
dc.identifier.urihttp://hdl.handle.net/10366/167455
dc.description.abstract[EN]This dataset contains raw spectral flow cytometry files (FCS format) generated in a mouse immunization study evaluating an mRNA–lipid nanoparticle (mRNA-LNP) vaccine candidate encoding the Fasciola hepatica fatty-acid–binding protein (FABP). BALB/c mice (n = 6 per group) received a prime–boost immunization regimen (3 weeks apart) with either mRNA-LNP–FABP or control formulations. Peripheral blood was collected longitudinally at multiple time points post-vaccination, and spleens were harvested at study endpoint for immune profiling. Samples were acquired using a spectral flow cytometer (model, manufacturer) with a XX-color panel designed to assess innate and adaptive immune populations. Each FCS file corresponds to an individual sample (blood or spleen) and includes metadata identifying the animal ID, group, time point, and tissue of origin. The dataset enables analysis of vaccine-induced immune responses, including innate activation, T-cell differentiation, and B-cell maturation.es_ES
dc.description.sponsorshipFinancial support from Grant PID2022-136462NB-I00 funded by “Ministerio de Ciencia e Innovación” and cofinanced by “European Union”. T.S. and M.A.G.-B. Acknowledge funding from the University of Virginia. J.S.-M. acknowledges the predoctoral fellowship program of Junta de Castilla y León, co-funded by “Fondo Social Europeo” (Orden EDU875/2021). CT was supported by an Andrés Laguna fellowship (Junta de Castilla y León, co-financed by the Fondo Social Europeo Plus, FSE+; ORDEN EDU/300/2025).es_ES
dc.language.isoenges_ES
dc.publisherUniversidad de Salamancaes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectFasciola hepaticaes_ES
dc.subjectParasitees_ES
dc.subjectTrematodees_ES
dc.subjectmRNAes_ES
dc.subjectVaccinees_ES
dc.subjectCytometryes_ES
dc.subjectFABPes_ES
dc.titleRaw data of Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a Fatty Acid Binding Protein vaccine [Dataset]es_ES
dc.typeinfo:eu-repo/semantics/datasetes_ES
dc.subject.unesco32 Ciencias Médicases_ES
dc.subject.unesco24 Ciencias de la Vidaes_ES
dc.identifier.doi10.71636/zmp6-m645
dc.relation.projectIDGrant PID2022-136462NB-I00es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.publication.year2025


Dateien zu dieser Ressource

Thumbnail
Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional